Since November 2021, I've been bullish on Pfizer (PFE) stock, actively arguing that the LOEs they were supposed to go through weren't actually changing the long-term fundamental picture: The firm's ...
Pfizer's stock has been trading at low levels for a while. Diminished growth and concerns about the future have investors thinking twice about the stock. The company did show signs of progress in its ...
STOXX 600 marks fifth week of gains Pfizer COVID-19 pill turbo-charges travel stocks Allegro surges after Mall Group deal German, French stocks scale new peaks Nov 5 (Reuters) - European equities ...
Both Ford and Pfizer have very attractive dividend yields.
Pfizer shares were lower on Tuesday despite third-quarter financial results that came in ahead of expectations. Sales of a few important products fell short. Adjusted diluted earnings came in at $0.87 ...
Pfizer will match its drug prices with those in other developed countries and will avoid paying any tariffs as long as it invests more in U.S. manufacturing Pfizer's stock surged after CEO Albert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results